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Abstract
We develop a Bayesian methodology for nonparametric estimation of ROC curves
used for evaluation of the accuracy of a diagnostic procedure. We consider the situation
where there is no perfect reference test, i.e., no \gold standard". The method is based
on a multinomial model for the joint distribution of test-positive and test-negative
observations. We use a Bayesian approach which assures the natural monotonicity
property of the resulting ROC curve estimate. MCMC methods are used to compute
the posterior estimates of the sensitivities and speci¯cities that provide the basis for
inference concerning the accuracy of the diagnostic procedure. Because there is no gold
standard, identi¯ability requires that the data come from at least two populations with
1di®erent prevalences. No assumption is needed concerning the shape of the distribu-
tions of test values of the diseased and non-diseased in these populations. We discuss
an application to an analysis of ELISA scores in the diagnostic testing of paratubercu-
losis (Johne's Disease) for several herds of dairy cows and compare the results to those
obtained from some previously proposed methods.
Key Words: Bayesian, Johne's Disease, Markov chain Monte Carlo, No Gold
Standard, Nonparametric, ROC curves
1 Introduction
In the diagnostic testing of certain diseases, \gold standard" (GS) tests (i.e., those with
error-free classi¯cation of diseased and disease-free individuals) are often too expensive to
use on a large scale, or may not even exist. Therefore, imperfect diagnostic tests are widely
used in medical and epidemiological research, especially when investigating disease in large
populations (Hui and Walter 1980; Joseph, Gyorkos, and Coupal 1995; Nielsen, Gronbak,
Agger, and Houe 2002). Yet when no GS tests are available for comparison, the performances
of these imperfect tests are di±cult to evaluate.
This paper was motivated by the need for accurate diagnostic tests for Johne's disease
in cattle. As part of the New York State Cattle Health Assurance Program, the Animal
Health Diagnostic Laboratory at Cornell University provides diagnostic services to dairy
herds throughout the northeastern United States. More than 760 herds and 80,000 cows
are tested annually. A recent report of the National Research Council of the U.S. National
Academies of Science (Rideout et al. 2003) has identi¯ed Johne's disease as a signi¯cant
animal health problem whose study and control deserves high priority from the USDA and
other national and state agencies. It recognized that one of the problems with Johne's
disease is the lack of speci¯c and sensitive tests for detecting early infections. In particular,
2no gold standard test exists. Therefore statistical methods are needed to assess both existing
diagnostic tests and ones yet to be proposed.
Consider ¯rst diagnostic tests with binary outcomes (positive or negative). Sensitivity
(Se, probability of a positive outcome in a diseased individual) and speci¯city (Sp, proba-
bility of a negative outcome in a non-diseased individual) are used to assess the accuracy of
such tests { see e.g., Pepe (2003, Chapter 2). In the case when there is no gold standard to
determine an individual's disease status, methods have been developed to evaluate the sensi-
tivities and speci¯cities of two imperfect tests by comparing one test to the other. A simple
and popular maximum likelihood (ML) approach was introduced by Hui and Walter (1980),
assuming the existence of two or more population strata with di®erent prevalences. They
also require the assumption of independence of test results conditional on disease status.
Joseph et al. (1995) developed Bayesian methods for evaluating conditionally independent
diagnostic tests, avoiding the need to stratify the population. However, their method has
been criticized by Andersen (1997) and Johnson, Gastwirth, and Pearson (2001) for lack
of identi¯ability; that is, the posterior distributions for some of the quantities of interest
need not become concentrated around their true values as the sample size increases. Sev-
eral models allowing for conditional dependence have been proposed using either ML or
Bayesian estimation, e.g., Qu, Tan, and Kutner (1996), Yang and Becker (1997), Dendukuri
and Joseph (2001), Black and Craig (2002), Garrett, Eaton, and Zeger (2002), Georgiadis,
Johnson, Gardner, and Singh (2003) and Hanson, Johnson, and Gardner (2003). Reviews of
methods for estimating the validity of two imperfect binary tests are presented in Walter and
Irwig (1988), Hui and Zhou (1998), En¿e, Georgiadis, and Johnson (2000) and Branscum,
Gardner, and Johnson (2005). All these methods deal with evaluation of imperfect binary
tests and cannot be applied to multichromatic or continuous-scaled tests.
The measurement scale of most serodiagnostic tests is usually ordinal or continuous. A
3value on this scale is selected as a decision threshold (cuto® value) to de¯ne positive and
negative test outcomes. Of course, sensitivity and speci¯city of a diagnostic test depend on
the choice of cuto® value and are inversely related. To assess the accuracy of a diagnostic
procedure, it is useful to consider the receiver operating characteristic (ROC) curve, which
is a graph of pairs of sensitivity and 1-speci¯city values that result as the test's cuto® value
is varied. ROC analysis is important for full test evaluation and test comparison, as well
as for the optimal choice of cuto® value (Greiner, Pfei®er, and Smith 2000). Principles of
ROC curve estimation using parametric and nonparametric methods are well described in
Pepe (2003). Traditional ROC analysis assumes the existence of a GS reference test that
has perfect sensitivity and speci¯city. Less work has been done for estimating ROC curves
without gold standard tests; this is summarized in the following two paragraphs.
When trying to compute an ROC curve when the true disease state is unknown, one
approach in the literature has been to estimate the pair (sensitivity, 1-speci¯city) for every
single cuto®-value separately by the maximum likelihood (ML) method of Hui and Walter
(1980), and then link them together to get the curve (Nielsen et al. 2002). We term this the
\separate MLE" method. However, an ROC curve with (Se,1-Sp) produced by this method
is not necessarily monotone, as in Nielsen et al. (2002, Figures 2, 3, 4, 5), and as we will see
in Figure 1 later in Section 4 of this paper. This non-monotonicity phenomenon is due to the
random aspect of the counts observed, and it contradicts the fact that ROC curves should
be monotone. Henkelman, Kay, and Bronskill (1990) have proposed a maximum likelihood
estimation method for the ROC curve of an ordinal-scale test using a multivariate normal
mixture latent model, however several limitations were pointed out by Begg and Metz (1990),
including the necessity to make a normality assumption . The method of Henkelman et al.
(1990) was later developed further by Beiden, Campbell, Meier, and Wagner (2000). Choi,
Johnson, Collins, and Gardner (2006) have proposed a parametric Bayesian method for ROC
4curve estimation in the absence of a gold standard where the test values (or transformed test
values) of both diseased and non-diseased individuals were measured on a continuous-scale
and normally distributed. Both methods of Henkelman et al. (1990) and Choi et al. (2006)
guarantee monotonicity; however, in the absence of a GS test, it is impossible to determine
the validity of the parametric distribution assumptions. Choi et al. (2006) have discussed
this in their paper and commented that a nonparametric approach could overcome such
di±culties.
Hall and Zhou (2003) proposed a nonparametric estimator for the ROC curves of continuous-
scale tests under the conditional independence assumption when the number of tests is three
or more. Zhou, Castelluccio, and Zhou (2005) applied the idea of Hall and Zhou (2003) to
estimate an ROC curve and its associated AUC (area under curve) of a ordinal-scale test
with the EM algorithm. The methods of both articles deal speci¯cally with the situation of
one population (i.e., probability of disease must be same for every individual in the study);
thus identi¯ability requires at least three tests available. Also in the work of Zhou et al.
(2005), all the di®erent tests should be based on the same ordinal scale. The computations
in the methods of both articles are complicated by the existence of many local maxima of
the likelihood function, as discussed by the authors.
For our study of Johne's Disease, we need to evaluate an imperfect continuous-scaled
test by comparing it to an imperfect reference binary test (see Section 4 for further details).
Hence, the method by Nielsen et al. (2002) is the only one in the current literature that
could be applied in this situation. Yet, as we have discussed previously, this method can
su®er from the disadvantage of producing a non-monotone estimated ROC curve. In this
paper, we propose a nonparametric method based on Bayesian models to estimate the (Se,
1-Sp) pairs jointly, without any assumption concerning the shapes of the distributions of test
values. MCMC methods are used to compute the posterior estimates of the sensitivities and
5speci¯cities that provide the basis for inference concerning the accuracy of the diagnostic
procedure. Our approach assures the monotone property of the resulting ROC curves. We
discuss an application to the assessment of ELISA scores measured on a continuous scale for
the diagnostic testing of Johne's Disease by comparing with fecal culture (FC) test result {
an imperfect binary test. Our data come from 2662 cows in 55 herds. We also carry out the
method of Nielsen et al. (2002) and compare the results.
In Section 6 we discuss extensions of our methods. In particular, we indicate how our
method can be generalized when the scale of the imperfect reference test is ordinal or con-
tinuous.
2 Ordered Multinomial Model Structure
The goal is to estimate the ROC curve of a new diagnostic procedure (Test 1) measured on
an ordinal or continuous scale by comparing it to an imperfect binary reference test (Test 2).
Let the two kinds of tests be applied simultaneously to each individual in samples from G
populations (or G strata within a population). Without loss of generality, high values for
Test 1 are associated with a high likelihood of presence of disease. For any binary test T,
denote the event that the test is positive for a given individual by T+, and negative by T¡.
For a given value of K, we select K increasing cuto® values for Test 1. Here K and the
cuto® values may be chosen arbitrarily; we discuss desirable choices later. For the i'th cuto®
value (1 · i · K) of Test 1, let T1;i denote the corresponding dichotomized test. Let ®1;i,
¯1;i be the corresponding unknown false positive rate (1¡speci¯city) and false negative rate
(1¡sensitivity), respectively, of this test T1;i. In addition de¯ne T1;0 as a test that always
yields a positive outcome and T1;K+1 as a test that is always negative. Correspondingly,
de¯ne ®1;0 = ¯1;K+1 = 1 and ®1;K+1 = ¯1;0 = 0. Note that, because the K cuto® values for
6Test 1 are increasing, the error rates are ordered:
1 = ®1;0 ¸ ®1;1 ¸ ®1;2 ¸ ::: ¸ ®1;K ¸ ®1;K+1 = 0;
0 = ¯1;0 · ¯1;1 · ¯1;2 · ::: · ¯1;K · ¯1;K+1 = 1:
Let ®2, ¯2 be the unknown false positive and false negative rates of Test 2, respectively.
Recall Test 2 is measured on a binary scale. We assume that these error rates for Test 1 and
Test 2 do not depend on the population g. This is reasonable as they are typically solely
properties of the tests themselves. Note that if Test 2 is based on an ordinal or continuous
scale, it could be dichotomized using a single cuto® value in order to use the methodology
described here. However, this will lead to some consequent loss of information. We discuss
this point further in Section 6.
In the gth population (1 · g · G), let µg be the unknown prevalence of disease and Ng
be the sample size. Of these Ng suppose mg are declared positive by Test 2 and ng = Ng¡mg
are negative by Test 2. Using the i'th cuto® value (1 · i · K) for Test 1, let yi;g;1, be the
frequency of (T1;i+;T2+) outcomes, that is the number of individuals in population g that
test positive both by test T1;i and by test T2. Similarly de¯ne yi;g;2 to be the frequency of
(T1;i+;T2¡) outcomes (1 · i · K;1 · g · G). Further, corresponding to our de¯nitions
of T1;0 and T1;K+1, we de¯ne y0;g;1 = mg;y0;g;2 = ng and yK+1;g;1 = yK+1;g;2 = 0. Note
that, because the K cuto® values for Test 1 are increasing, we have that the frequencies are
decreasing. That is
mg = y0;g;1 ¸ y1;g;1 ¸ ::: ¸ yK;g;1 ¸ yK+1;g;1 = 0;
ng = y0;g;2 ¸ y1;g;2 ¸ ::: ¸ yK;g;2 ¸ yK+1;g;2 = 0:
Assuming independence between the two tests conditional on the true disease state, we
7can write down expressions for the corresponding probabilities:
PrfT1;i+;T2+g = µg(1 ¡ ¯1;i)(1 ¡ ¯2) + (1 ¡ µg)®1;i®2; (1)
PrfT1;i+;T2¡g = µg(1 ¡ ¯1;i)¯2 + (1 ¡ µg)®1;i(1 ¡ ®2): (2)
To obtain the entire ROC curve for Test 1, we now need consider all the possible K cuto®
values for Test 1 simultaneously. For i = 1;:::;K + 1 and g = 1;:::G, let
pi;g = PrfT1;i¡1+;T1;i¡;T2+g = PrfT1;i¡1+;T2+g ¡ PrfT1;i+;T2+g (3)
be the probability that an individual in group g, who was positive by Test 2, was positive
by Test 1 using the (i ¡ 1)th cuto® but negative using the ith cuto®. Similarly de¯ne
qi;g = PrfT1;i¡1+;T1;i¡;T2¡g = PrfT1;i¡1+;T2¡g ¡ PrfT1;i+;T2¡g (4)
for individuals who were negative by Test 2. Finally let the observed frequencies, corre-
sponding to the fpi;gg and fqi;gg, be denoted by:
xi;g;1 = yi¡1;g;1 ¡ yi;g;1;
xi;g;2 = yi¡1;g;2 ¡ yi;g;2
for i = 1;:::;K + 1 and g = 1;:::;G, respectively. These frequencies and probabilities for
population g can be displayed in a 2£(K+1) table | see Table 1. In this table, the columns
labelled fT1;i¡;T1;i¡1+g are for individuals classi¯ed positive by T1;i¡1 but negative by T1;i.
These are divided between those classi¯ed positive by Test 2 (¯rst row) and those classi¯ed
negative by Test 2 (second row).
[Table 1 about here.]
Using (1{4), we have that the cell probabilities are given by:
pi;g = µgbi(1 ¡ ¯2) + (1 ¡ µg)ai®2; (5)
qi;g = µgbi¯2 + (1 ¡ µg)ai(1 ¡ ®2) (6)
8where, for i = 1;2;::;K + 1, we have de¯ned:
ai = ®1;i¡1 ¡ ®1;i; (7)
bi = ¯1;i ¡ ¯1;i¡1 (8)
and where a = (a1;:::;aK+1), etc. Note relationships (7) and (8) de¯ne one-to-one mappings
between the f®ig and the faig and between the f¯ig and the fbig. Also note that:
K+1 X
i=1
ai =
K+1 X
i=1
®1;i¡1 ¡ ®1;i = ®1;0 ¡ ®1;K+1 = 1;
K+1 X
i=1
bi =
K+1 X
i=1
¯1;i ¡ ¯1;i¡1 = ¯1;K+1 ¡ ¯1;0 = 1:
The observed frequencies fxi;g;1g and fxi;g;2g for 1 · i · K + 1; 1 · g · G have a
likelihood of a product of G multinomials each with K + 1 categories:
L(xja;b;®2;¯2;µ) (9)
/
G Y
g=1
K+1 Y
i=1
[µgbi(1 ¡ ¯2) + (1 ¡ µg)ai®2]
xi;g;1 ¢ [µgbi¯2 + (1 ¡ µg)ai(1 ¡ ®2)]
xi;g;2
where a = (a1;:::;aK+1) etc.
In the model, there are a total of 2K +G+2 unknown parameters, namely ®1;1;:::;®1;K,
¯1;1;:::;¯1;K, µ1;:::;µG, ®2;¯2, and G(2K +1) degrees of freedom. Thus we need G ¸ 2 with
at least two of the µg-values distinct in order to make the model identi¯able. This can also
be seen by examining the likelihood (9) directly. In practice, no two distinct populations
will have identical prevalences. However, the true values could be \close"; we discuss this
situation further in Section 5. In addition, we see that we also need ®2 + ¯2 6= 1 for
the model to be identi¯able for otherwise (9) depends on µg;faig;fbig only through the
fµgbi + (1 ¡ µg)aig. Intuitively, ®2 + ¯2 = 1 implies that Test 2 is no better than random
guessing and so contributes no information. Presumably, such a test would not be under
9consideration { see further comments in Section 5. It can also be seen that (9) remains
unchanged under the transformation b0
i = ai; a0
i = bi;µ0
g = 1 ¡ µg;®0
2 = 1 ¡ ¯2; ¯0
2 = 1 ¡ ®2.
Hence for identi¯ability, we may assume ®2+¯2 < 1. In fact, this is without loss of generality:
If ®2 + ¯2 > 1, which is worse than random guessing, we could always use the test criterion
in the opposite direction to obtain a test which is better than random guessing and now has
®2 + ¯2 < 1.
In order to guarantee the monotonicity of the ROC curve, a and b need to be constrained
as non-negative. We implement this by taking a Bayesian approach and placing Dirichlet
priors on the parameters a and b.
3 The Bayesian Approach
Suppose we specify a prior distribution with density ¼(a;b;®2;¯2;µ) for all the parameters
in our model. Here we use appropriate conjugate priors, as will be described later in this
section. In the Bayesian approach, inference concerning the parameters is based on the
posterior density:
¼(a;b;®2;¯2;µjx) (10)
/ L(xja;b;®2;¯2;µ) ¢ ¼(a;b;®2;¯2;µ)
/
G Y
g=1
K+1 Y
i=1
[µgbi(1 ¡ ¯2) + (1 ¡ µg)ai®2]
xi;g;1 ¢ [µgbi¯2 + (1 ¡ µg)ai(1 ¡ ®2)]
xi;g;2
£¼(a;b;®2;¯2;µ):
The Bayesian estimates of the parameters are given by their means from this posterior
distribution. These posterior means are computed using Markov chain Monte Carlo (MCMC)
methods | e.g., see Robert and Casella (2004). In particular, we propose to use the Gibbs
sampling algorithm. The Gibbs sampler is an iterative algorithm for generation of samples
of variables (parameter values) from the posterior multivariate distribution. It proceeds
10by successively updating each variable by sampling from its conditional distribution given
current values of all other variables. After a su±ciently large number of iterations, under
mild conditions it can be proven that the values of the updated variables so obtained form a
sample from the joint posterior distribution | see for example, Robert and Casella (2004).
First however, we note from inspection of (10) that it is not easy to construct the con-
ditional distributions needed for the Gibbs sampler directly from the density. In order to
take advantage of Gibbs sampling, we solve this problem by using data augmentation as
described by Tanner and Wong (1987). This is as follows.
In the g'th population, the vector xg = (x1;g;1;:::;xK+1;g;1;x1;g;2;:::;xK+1;g;2) has a 2(K+1)-
dimensional multinomial likelihood, namely
xg » Mul2(K+1)(Ng;p1;g;:::;pK+1;g;q1;g;:::;qK+1;g)
where Ng is the sample size of the g'th population.
As calculated before,
pi;g = µgbi(1 ¡ ¯2) + (1 ¡ µg)ai®2;
qi;g = µgbi¯2 + (1 ¡ µg)ai(1 ¡ ®2):
This may be viewed as a grouped multinomial problem, if we introduce new random vectors
ug = (u1;g;1;:::;uK+1;g;1;u1;g;2;:::;uK+1;g;2) for all g = 1;::;G. Let
(u1;g;1;x1;g;1 ¡ u1;g;1;:::;uK+1;g;1;xK+1;g;1 ¡ uK+1;g;1;
u1;g;2;x1;g;2 ¡ u1;g;2;:::;uK+1;g;2;xK+1;g;2 ¡ uK+1;g;2)
» Mul4(K+1)(Ng;µgb1(1 ¡ ¯2);(1 ¡ µg)a1®2;:::;µgbK+1(1 ¡ ¯2);(1 ¡ µg)aK+1®2;
µgb1¯2;(1 ¡ µg)a1(1 ¡ ®2);:::;µgbK+1¯2;(1 ¡ µg)aK+1(1 ¡ ®2)):
Then the marginal distribution of xg will remain the same as in the original model. However
the augmented data likelihood in the new multinomial distribution is of a more tractable
11form, permitting use of conjugate priors:
L(x;uja;b;®2;¯2;µ)
/
G Y
g=1
K+1 Y
i=1
f[µgbi(1 ¡ ¯2)]
ui;g;1 ¢ [(1 ¡ µg)ai®2]
xi;g;1¡ui;g;1
¢ [µgbi¯2]
ui;g;2 ¢ [(1 ¡ µg)ai(1 ¡ ®2)]
xi;g;2¡ui;g;2g
= [
K+1 Y
i=1
a
PG
g=1(xi;g;1¡ui;g;1+xi;g;2¡ui;g;2)
i ] ¢ [
K+1 Y
i=1
b
PG
g=1(ui;g;1+ui;g;2)
i ] ¢ ®
PG
g=1
PK+1
i=1 (xi;g;1¡ui;g;1)
2
¢(1 ¡ ®2)
PG
g=1
PK+1
i=1 (xi;g;2¡ui;g;2) ¢ ¯
PG
g=1
PK+1
i=1 ui;g;2
2 ¢ (1 ¡ ¯2)
PG
g=1
PK+1
i=1 ui;g;1
¢[
G Y
g=1
µ
PK+1
i=1 (ui;g;1+ui;g;2)
g (1 ¡ µg)
PK+1
i=1 (xi;g;1¡ui;g;1+xi;g;2¡ui;g;2)]:
Now
PK+1
i=1 ai =
PK+1
i=1 bi = 1, so the natural conjugate priors for a, b are Dirichlet
distributions, while for ®2;¯2;µ1;:::;µG they are all Beta distributions. Speci¯cally, as a
prior for a, we take Dirich(h1;:::;hK+1):
¼(a) /
K+1 Y
i=1
a
hi¡1
i ;
for b, we use prior Dirich(hK+2;:::;h2K+2):
¼(b) /
K+1 Y
i=1
b
hK+1+i¡1
i ;
for ®2, we use prior Beta(h2K+3;h2K+4):
¼(®2) / ®
h2K+3¡1
2 (1 ¡ ®2)
h2K+4¡1;
for ¯2, we use prior Beta(h2K+5;h2K+6):
¼(¯2) / ¯
h2K+5¡1
2 (1 ¡ ¯2)
h2K+6¡1;
and for µg, g = 1;:::;G, we use prior Beta(h2K+5+2g;h2K+6+2g):
¼(µg) / µ
h2K+5+2g¡1
g (1 ¡ µg)
h2K+6+2g¡1:
12Informative priors will be preferred whenever previous knowledge is available for any of the
parameters (error rates or prevalences). Otherwise h1 = ::: = hK+1 = 1=2, hK+2 = ::: =
h2K+2 = 1=2, h2K+3 = h2K+4 = 1=2, h2K+5 = h2K+6 = 1=2, h2K+5+2g = h2K+6+2g = 1=2
can be taken as noninformative priors for a, b, ®2, ¯2, µg respectively. Sensitivity analyses
for di®erent priors have been performed by Gustafson (2005) in the context of binary tests
evaluation without a GS. Our priors are natural to use for the models in this paper. As
discussed in the previous section, we add the identi¯ability constraint ®2 + ¯2 < 1 into the
prior.
Finally, the augmented data posterior is obtained as:
¼(a;b;®2;¯2;µjx;u) (11)
/
"
K+1 Y
i=1
a
hi¡1+
PG
g=1(xi;g;1¡ui;g;1+xi;g;2¡ui;g;2)
i
#
£
"
K+1 Y
i=1
b
hK+1+i¡1+
PG
g=1(ui;g;1+ui;g;2)
i
#
£
·
®
h2K+3¡1+
PG
g=1
PK+1
i=1 (xi;g;1¡ui;g;1)
2 ¢ (1 ¡ ®2)
h2K+4¡1+
PG
g=1
PK+1
i=1 (xi;g;2¡ui;g;2)
¸
£
·
¯
h2K+5¡1+
PG
g=1
PK+1
i=1 ui;g;2
2 ¢ (1 ¡ ¯2)
h2K+6¡1+
PG
g=1
PK+1
i=1 ui;g;1
¸
£
"
G Y
g=1
µ
h2K+5+2g¡1+
PK+1
i=1 (ui;g;1+ui;g;2)
g (1 ¡ µg)
h2K+6+2g¡1+
PK+1
i=1 (xi;g;1¡ui;g;1+xi;g;2¡ui;g;2)
#
£ I(®2 + ¯2 < 1):
We can update the values in the chain by Gibbs sampling from the full conditional prob-
abilities. These are given in the Appendix. The Gibbs sampling is programmed in MATLAB
version 7.0 (The MathWorks, Inc. 2004). We have found this approach to be preferred to
WinBUGS (Spiegelhalter, Thomas, Best, and Gilks 1995) on grounds of computing speed.
Source code is available upon request from the ¯rst author.
134 Application to Johne's Disease
As stated in Section 1, our original motivation for the methodology developed in this paper
came from the diagnostic testing for paratuberculosis (Johne's Disease) in cattle at the Ani-
mal Health Diagnostic Laboratory at Cornell University . For this disease there is no agreed
GS test. Two di®erent (imperfect) tests are employed: fecal culture (FC), a test with cate-
gorical outcomes (here, just two { positive or negative); and enzyme-linked immunosorbent
assay (ELISA), the readings of which can be regarded as continuous. Because the ELISA test
takes a relatively short time and is inexpensive, the Laboratory is interested in evaluating
its performance.
The conditional independence of the FC and ELISA tests can be justi¯ed on biological
grounds. FC measures bacterial shedding, which can occur from the time of infection to
the death of the animal, though the probability increases with progression of the disease.
ELISA measures occurrence of antibodies, which require that a shift from cell-mediated
immune responses to humoral immune responses has occurred (Stabel 2000).
4.1 Johne's Disease Data Analysis
In this section, the ELISA test (Test 1) is to be evaluated against the FC test (Test 2) for
the diagnosis of Johne's Disease. The cross-sectional data set to be used is from part of a
multipurpose study on infectious disease in a study carried out by the Danish dairy board
in Southern Jutland, Denmark, in 1998 (Andersen et al. 2000). It is similar to the data sets
that have been used in Nielsen et al. (2002). The 2662 cows from 55 herds in the data set
are divided into two groups ( G=2 ) by veterinary practitioner of the farm. The split was
based on the median of an ordered list of the veterinary o±cial federal practice codes. This
criterion was used by Nielsen et al. to select the groups and, according to their Table 3, it
14would seem reasonable to assume the two groups have di®erent prevalences. They considered
two other ways to select the groups which we will discuss later in Section 4.2. The ELISA
test readings were analyzed based on corrected optical density (ODC) measurements. There
are a total of 1462 distinct corrected ODC-values, all of which could be used as e®ective
cuto® values in the analysis. After ordering the corrected ODC-values, we chose the set of
f1=(K + 1);2=(K + 1);:::;K=(K + 1)g-quantiles of the values to be used as cuto® values in
the model. Such a choice insures balanced frequencies in the columns of Table 1. Here we
considered several alternative values for K, namely K = 10;20;50;100.
Noninformative priors where h1 = ::: = h2K+6+2G = 1=2 have been used in this analysis to
compare the result with the separate ML approach. The method of Choi et al. (2006) cannot
be applied in this case because the outcome of the reference FC test is not measured on a
continuous scale. Four models with di®erent numbers of cuto® values have been implemented
to analyze the data, where K = 10, 20, 50, 100, respectively. The results are shown in
Figure 1. All four models have been run for 100,000 iterations and the samples from 50,001
to 100,000 are used to compute summary statistics.
[Figure 1 about here.]
As can be seen in Figure 1, the four Bayesian ROC estimates are very close in both shape
and position to the one produced by the method of separate ML estimates. However, the
Bayesian method produces monotone estimated ROC curves, which the other method does
not. The values of the area under the ROC curve (AUC) are 0.784, 0.785, 0.758, 0.748, for
K = 10, 20, 50, 100 respectively. As the number of cuto® values K increases from 10 to 100,
there are more points on the curve being estimated so that the ROC estimate is capable of
capturing more details. But, on the other hand, adding each new cuto® value will introduce
two more prior parameters into the model. So without increasing the sample size of the
15data, increasing K alone will make the model more sensitive to the prior information. In
practice, a larger K also leads to a larger number of samplings in each Gibbs iteration, thus
increasing the running time of the program. For the four cases where K = 10, 20, 50, 100,
the running times of the MATLAB program on a 2.80 GHz Pentium 4 processor per 1000
iterations are 3.67, 4.43, 5.56, 17.71 seconds, respectively.
[Figure 2 about here.]
Multiple chains have been simulated and pass the convergence criterion after the ¯rst
5,000 iterations. Convergence has been checked using CODA (Convergence Diagnostic and
Output Analysis) software (Best, Cowles, and Vines 1995) and passes all six di®erent conver-
gence diagnostic criteria. For the particular model with K = 20, the ¯rst 10,000 iterations
of the error rates ®1;1, ®1;10, ®1;19, ¯1;1, ¯1;10, ¯1;19 are plotted in Figure 2. Figure 3 (upper
panel) shows estimated ROC curve based on the posterior means. Also shown are the §
standard deviation band and the 95% credible band based on 2.5% and 97.5% quantiles
of the posterior distribution. In the lower panel of Figure 3, we reproduce our Bayesian
estimate of the ROC curve (a), along with the estimate based on using the separate MLE
method (b) of Nielsen et al. (2002) and (c) the usual estimate that would be obtained if the
fecal culture test was incorrectly assumed to be a GS test. Note that the estimate (b) is
non-monotone and that the estimate (c) lies below (a) with a lower AUC.
The estimates (95% credible interval) for the speci¯city (1-®2) and sensitivity (1-¯2) for
the FC test are estimated as 0.988 (0.975,0.999) and 0.830 (0.507,0.999), respectively. The
estimate of sensitivity of the FC test may seem higher than generally accepted; however, its
credible interval is wide and contains most of the di®erent estimates reported in Nielsen et al.
(2002, Table 5), which were based on the same data set. The estimate for FC sensitivity
could be interpreted as the sensitivity of an animal with some level of antibodies. The
16prevalences (µ1, µ2) in the two populations are estimated as 0.030 and 0.080, with a 95%
credible interval for the di®erence being (0.027,0.083). Note that this interval excludes zero.
These estimates are of the same order of magnitude that have been reported in other studies,
{ e.g., Nielsen et al. (2002, Table 3 and 5).
[Figure 3 about here.]
4.2 Robustness with respect to division of population
Both the ML estimation and the Bayesian methods require division of the full population
into two or more distinct subpopulations with di®erent prevalences. In their study of the
same Johne's disease data set, Nielsen et al. (2002) examined three division criteria, all of
which are based on non-biological risk factors. Besides veterinary practitioner of the farm
(Vet) which we used in Section 4.1, their other two criteria were: herd size (Size) and postal
zip code (Zip). Size was divided at 100 cows, Zip was divided based on the median of postal
codes in an ordered list.
We repeated our analyses of Section 4.1 for the other two methods of division. The
ROC curve estimates obtained by the separate ML method (upper panel of Figure 4) appear
to be di®erent in shape and position for the three division criteria. However, as can be
seen in the lower panel of Figure 4, the Bayesian ROC estimates obtained from the three
division criteria are almost the same. Intuitively, in the Bayesian model, the information
from di®erent cuto® values are considered jointly, and thus the aberrant observations can
not a®ect the ROC curve estimates as much as they would if the separate ML method were
used. Thus the nonparametric method we propose here should be more robust to the impact
of di®erent division criteria on the ROC estimation. The estimates of the two prevalence
quantities corresponding to the three ways to split the population were Vet: 0.030, 0.080 (as
17in Section 4.1); Size: 0.044, 0.107; and Zip: 0.013, 0.068. Also, the 95% credible intervals
for the di®erence in prevalences excluded 0 for all three division methods.
[Figure 4 about here.]
5 Discussion
It is important to investigate how well the proposed ROC estimation procedure performs.
To answer this question, a moderate size simulation study was undertaken. First, a hundred
data sets mimicking the Johne's disease data set analyzed in Section 4.1 were simulated. Each
data set contained two populations (G = 2), with 1250 individuals in each (n1 = n2 = 1250).
For each individual in the g'th population (g = 1;2), we ¯rst simulated the true disease
status (0 for healthy and 1 for diseased) according to a binomial distribution Bin(1;µg), using
prevalences µ1 = 0:03; µ2 = 0:08. Then, for each diseased individual in either population,
a Test 1 score is generated from a normal distribution N(¹1 = +0:33;¾2
1 = 0:63 ) and a
Test 2 score of 0 (negative) or 1 (positive) is generated with probabilities ¯2 = 0:17, and
1¡¯2 = 0:83, respectively. Similarly, for each healthy individual, a Test 1 score is generated
from a N(¹0 = ¡0:33;¾2
00:12) distribution and a Test 2 score of 0 or 1 is generated with
probabilities 1 ¡ ®2 = 0:98, and ®2 = 0:02, respectively. These ® and ¯ values were taken
from the estimates reported in Section 4.1; the ¹ and ¾ values for the binormal model of
Test 1 scores lead to an ROC curve similar to our Bayesian estimate in Figure 3 with a
similar AUC of 0.78.
[Table 2 about here.]
It can be seen that the procedure does very well in estimating the true accuracy of Test 1
as measured by the AUC value. The estimates of Se2 are not as accurate; however, it should
18be realized that that the disease prevalences here are low and so sensitivities are based on
a small proportion of the population. Hence it is not surprising that the standard deviation
of the Se2 estimate is higher.
The results reported in Table 2 represent just part of a larger simulation study that was
conducted in order to evaluate the performance of the estimation procedure for a variety of
situations. That larger study was designed as a 2 £ 3 £ 3 factorial experiment in which 18
di®erent combinations of parameter values were used | leading to the creation of 1800 data
sets. Because of space limitations, the results are reported separately in a Technical Report
available from the authors.
For these di®erent 18 scenarios, the procedure performed similarly as in Table 2. However,
for true Test 1 AUC values close to 1, the estimation procedure underestimated the AUC.
This is natural since 1 is an upper bound. In this case, improved estimates can be obtained
by increasing the number K of cuto® points. Alternatively, instead of taking evenly spaced
quantiles, an increased proportion of the cuto® values may be taken over the range of the
diseased population measurements (assuming the prevalence is less than 0.5). This will lead
to more cuto® points in the region where the sensitivity is increasing to 1, which happens
rapidly on the ROC curve in this situation when the AUC is close to 1.
It is also of interest to ask what happens with the estimation procedure when the true
(unknown) model happens to be non-identi¯able. In fact, of the 18 scenarios in our simulation
study, 12 had non-identi¯able con¯gurations of parameters in which either µ1 = µ2 or ®2 +
¯2 = 1 or both. In this case we would not expect that the procedure to perform well at
all, although in fact, for most of the situations considered, the Test 1 AUC values were still
estimated quite accurately. Of course, these situations cannot really occur in practice. First,
no two populations can have exactly identical prevalences. Second, ®2 +¯2 = 1 implies that
Test 2 is no better than random guessing; it is unlikely that such a test would be employed
19in an expensive experiment. However, it is important to know when the true parameters
are \close" to a non-identi¯able con¯guration. We propose two rules for °agging potential
problem con¯gurations that can be used as warnings.
1. Flag 1. The 95% credible interval (CI) for µ1 ¡ µ2 includes 0.
2. Flag 2. The sum of upper bounds of the 95% CIs for ®2 and for ¯2 is larger than 1.
None of the 100 simulations in Table 2 resulted in any °ag, which gives added con¯dence
to the results reported in Section 4.1. In the larger simulation study, 0.5% of the analyses of
the 600 datasets for six scenarios with identi¯able con¯gurations resulted in a °ag. On the
contrary, the number of analyses °agged ranged from 92% to 98% for twelve scenarios with
non-identi¯able con¯gurations. The details are given in the Technical report cited previously.
6 Conclusion
In conclusion, the monotonicity property of the resulting ROC curve estimate is guaranteed
by the model structure for the multinomial joint distribution of test-positive and test-negative
observations. No assumption is needed concerning the shape of the distributions of test values
of the diseased and non-diseased in these populations. The number of populations G may
take any value greater than or equal to two.
Our main focus has been to estimate the ROC curve of Test 1; the imperfect reference Test
2 is assumed to have binary outcomes in our model. However, an imperfect reference test with
multichromatic or continuous-scaled outcomes may also be analyzed using a generalization
of our approach, in which we consider K0(¸ 2) cuto®s for classi¯cation rather than simply
dichotomizing the Test 2 results. In this case, our model would be based on a (K0+1)(K+1)-
dimensional multinomial distribution instead of the 2(K + 1)-dimensional multinomial in
Section 2.
20Our model assumes independence between Test 1 and Test 2 conditional on the true
disease status. This assumption is reasonable if the tests have unrelated bases such as can
be argued in our application of Section 4. It has been widely used in the literature (Hui and
Walter 1980; Joseph et al. 1995; Zhou et al. 2005). This issue has been discussed in detail by
Albert and Dodd (2004) and Toft, J¿rgensen, and H¿jsgaard (2005) in the context of binary
tests evaluation. It would be an interesting extension to consider ROC curve estimation that
allows correlation between tests, still without a gold standard.
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APPENDIX: Full Conditional Distributions for Implementation of the Gibbs
Sampler
Based on the augmented data posterior (11), the full conditionals are sampled as follows.
For every i = 1;::;K;g = 1;::;G,
ui;g;1j² » Bin
µ
xi;g;1;
µgbi(1 ¡ ¯2)
µgbi(1 ¡ ¯2) + (1 ¡ µg)ai®2
¶
;
ui;g;2j² » Bin
µ
xi;g;2;
µgbi¯2
µgbi¯2 + (1 ¡ µg)ai(1 ¡ ®2)
¶
:
All these are Binomial distributions.
¼(aj²) /
K+1 Y
i=1
a
hi¡1+
PG
g=1(xi;g;1¡ui;g;1+xi;g;2¡ui;g;2)
i :
21Thus aj² is simulated from a Dirichlet distribution:
Dirich
Ã
h1 +
G X
g=1
(x1;g;1 ¡ u1;g;1 + x1;g;2 ¡ u1;g;2) ;:::;
hK+1 +
G X
g=1
(xK+1;g;1 ¡ uK+1;g;1 + xK+1;g;2 ¡ uK+1;g;2)
!
:
Similarly
¼(bj²) /
K+1 Y
i=1
b
hK+1+i¡1+
PG
g=1(ui;g;1+ui;g;2)
i
and bj² is simulated from a Dirichlet distribution:
Dirich
Ã
hK+2 +
G X
g=1
(u1;g;1 + u1;g;2);:::;h2K+2 +
G X
g=1
(uK+1;g;1 + uK+1;g;2)
!
:
Also
¼(®2j²) / ®
h2K+3¡1+
PG
g=1
PK+1
i=1 (xi;g;1¡ui;g;1)
2 ¢ (1 ¡ ®2)
h2K+4¡1+
PG
g=1
PK+1
i=1 (xi;g;2¡ui;g;2)
£ I(®2 + ¯2 < 1):
Thus ®2j² is simulated from a Beta distribution:
®2j² » Beta
Ã
h2K+3 +
G X
g=1
K+1 X
i=1
(xi;g;1 ¡ ui;g;1);h2K+4 +
G X
g=1
K+1 X
i=1
(xi;g;2 ¡ ui;g;2)
!
truncated by I(®2 + ¯2 < 1). Similarly
¼(¯2j²) / ¯
h2K+5¡1+
PG
g=1
PK+1
i=1 ui;g;2
2 ¢ (1 ¡ ¯2)
h2K+6¡1+
PG
g=1
PK+1
i=1 ui;g;1
£ I(®2 + ¯2 < 1):
Thus ¯2j² is simulated from a Beta distribution:
¯2j² » Beta
Ã
h2K+5 +
G X
g=1
K+1 X
i=1
ui;g;2;h2K+6 +
G X
g=1
K+1 X
i=1
ui;g;1
!
truncated by I(®2 + ¯2 < 1).
For every g = 1;::;G,
¼(µgj²) /
G Y
g=1
µ
h2K+5+2g¡1+
PK+1
i=1 (ui;g;1+ui;g;2)
g (1 ¡ µg)
h2K+6+2g¡1+
PK+1
i=1 (xi;g;1¡ui;g;1+xi;g;2¡ui;g;2):
22Thus
µgj² » Beta
Ã
h2K+5+2g +
K+1 X
i=1
(ui;g;1 + ui;g;2);
h2K+6+2g +
K+1 X
i=1
(xi;g;1 ¡ ui;g;1 + xi;g;2 ¡ ui;g;2)
!
:
References
Albert, P. S. and Dodd, L. E. (2004), \A Cautionary Note on the Robustness of Latent
Class Models for Estimating Diagnostic Error Without a Gold Standard," Biometrics, 60,
427{435.
Andersen, H. J., Aagaard, K., Skjoth, F., Rattenborg, E., and Enevoldsen, C. (2000), \In-
tegration of Research, Development, Health Promotion, and Milk Quality Assurance in
the Danish Dairy Industry," in Proceedings of the Ninth Symposium of the International
Society of Veterinary Epidemiology and Economics, Breckenridge, CO, August 6-11, eds.
Salman, M. D., Morley, P., and Ruch-Gallie, R., pp. 258{260.
Andersen, S. (1997), \Re: Bayesian Estimation of Disease Prevalence and the Parameters of
Diagnostic Tests in the Absence of a Gold Standard," American Journal of Epidemiology,
145, 290{291.
Begg, C. B. and Metz, C. E. (1990), \Consensus Diagnosis and "Gold Standards"," Medical
Decision Making, 10, 29{30.
Beiden, S. V., Campbell, G., Meier, K. L., and Wagner, R. F. (2000), \On the Problem
of ROC Analysis without Truth: The EM Algorithm and the Information Matrix," in
Proceedings of the Society of Photo-Optical Instrumentation Engineers (SPIE): The Inter-
23national Society for Optical Engineering, Bellingham WA,, eds. Salman, M. D., Morley,
P., and Ruch-Gallie, R., vol. 3981, pp. 126{134.
Best, N., Cowles, M., and Vines, S. (1995), CODA Manual version 0.30, Cambridge, UK:
MRC Biostatistics Unit.
Black, M. A. and Craig, B. A. (2002), \Estimating Disease Prevalence in the Absence of a
Gold Standard," Statistics in Medicine, 21, 2653{2669.
Branscum, A. J., Gardner, I. A., and Johnson, W. O. (2005), \Estimation of Diagnostic-test
Sensitivity and Speci¯city Through Bayesian Modeling," Preventive Veterinary Medicine,
68, 145{163.
Choi, Y., Johnson, W. O., Collins, M. T., and Gardner, I. A. (2006), \Bayesian Inferences
for Receiver Operating Characteristic Curves in the Absence of a Gold Standard," Journal
of Agricultural, Biological and Enviromental Statistics, 11, 210 { 229.
Dendukuri, N. and Joseph, L. (2001), \Bayesian Approaches to Modeling the Conditional
Dependence Between Multiple Diagnostic Tests," Biometrics, 57, 158 { 167.
En¿e, C., Georgiadis, M. P., and Johnson, W. O. (2000), \Estimation of Sensitivity and
Speci¯city of Diagnostic Tests and Disease Prevalence When the True Disease State is
Unknown." Preventive Veterinary Medicine, 45, 61{81.
Garrett, E. S., Eaton, E. E., and Zeger, S. (2002), \Methods for Evaluating the Performance
of Diagnostic Tests in the Absence of a Gold Standard: a Latent Class Model Approach,"
Statistics in Medicine, 21, 1289{1307.
Georgiadis, M. P., Johnson, W. O., Gardner, I. A., and Singh, R. (2003), \Correlation-
adjusted Estimation of Sensitivity and Speci¯city of Two Diagnostic Tests," Applied Sta-
tistics, 52, 63{76.
24Greiner, M., Pfei®er, D., and Smith, R. D. (2000), \Principles and Practical Application of
Receiver Operating Characteristic Analysis for Diagnostic Tests," Preventive Veterinary
Medicine, 45, 23{41.
Gustafson, P. (2005), \The Utility of Prior Information and Strati¯cation for Parameter
Estimation With Two Screening Tests but No Gold Standard," Statistics in Medicine, 24,
1203{1217.
Hall, P. and Zhou, X.-H. (2003), \Nonparametric Estimation of Component Distributions in
a Multivariate Mixture." Annals of Statistics, 31, 201{224.
Hanson, T. E., Johnson, W. O., and Gardner, I. A. (2003), \Hierarchical Models for the
Estimation of Disease Prevalence and the Sensitivity and Speci¯city of Dependent Tests
in the Absence of a Gold-standard," Journal of Agricultural, Biological and Enviromental
Statistics, 8, 223{239.
Henkelman, R. M., Kay, I., and Bronskill, M. J. (1990), \Receiver Operator Characteristic
(ROC) Analysis Without Truth," Medical Decision Making, 10, 24{29.
Hui, S. L. and Walter, S. D. (1980), \Estimating the Error Rates of Diagnostic Tests,"
Biometrics, 36, 167{171.
Hui, S. L. and Zhou, X. H. (1998), \Evaluation of Diagnostic Tests Without Gold Standards,"
Statistical Methods in Medical Research, 7, 354{370.
Johnson, W. O., Gastwirth, J. L., and Pearson, L. M. (2001), \Screening Without a "Gold
Standard": the Hui-Walter Paradigm Revisited," American Journal of Epidemiology, 153,
921{924.
Joseph, L., Gyorkos, T., and Coupal, L. (1995), \Bayesian Estimation of Disease Prevalence
25and the Parameters of Diagnostic Tests in the Absence of a Gold Standard," American
Journal of Epidemiology, 141, 263{272.
Nielsen, S. S., Gronbak, C., Agger, J. F., and Houe, H. (2002), \Maximum-likelihood Es-
timation of Sensitivity and Speci¯city of ELISAs and Faecal Culture for Diagnosis of
Paratuberculosis," Preventive Veterinary Medicine, 53, 191{204.
Pepe, M. (2003), The Statistical Evaluation of Medical Tests for Classi¯cation and Prediction,
New York: Oxford University Press.
Qu, Y., Tan, M., and Kutner, M. K. (1996), \Random E®ects Models for Evaluating Accu-
racy of Diagnostic Tests," Biometrics, 52, 797{810.
Rideout, B. A., Brown, S., Davis, W. C., Gay, J. M., Giannella, R. A., Hines, M. E., Hueston,
W. D., Hutchinson, L. J., and Rouse, T. (2003), The Diagnosis and Control of Johne's
Disease, Washington DC: National Academy Press.
Robert, C. P. and Casella, G. (2004), Monte Carlo Statistical Methods, 2nd ed., New York:
Springer.
Spiegelhalter, D. J., Thomas, A., Best, N. G., and Gilks, W. R. (1995), BUGS: Bayesian
Inference Using Gibbs Sampling, Version 0.50, Cambridge: MRC Biostatistics Unit.
Stabel, J. (2000), \Transitions in Immune Responses to Mycobacterium Paratuberculosis,"
Veterinary Microbiology, 77, 465{473.
Tanner, M. and Wong, W. (1987), \The Calculation Of Posterior Distributions By Data
Augmentation," Journal of the American Statistical Association, 82, 528{550.
The MathWorks, Inc. (2004), Getting Started with MATLAB, Version 7.
26Toft, N., J¿rgensen, E., and H¿jsgaard, S. (2005), \Diagnosing Diagnostic Tests: Evaluating
the Assumptions Underlying the Estimation of Sensitivity and Speci¯city in the Absence
of a Gold Standard," Preventive Veterinary Medicine, 68, 19{33.
Walter, S. D. and Irwig, L. M. (1988), \Estimation of Test Error Rates, Disease Prevalence
and Relative Risk From Misclassi¯ed Data - a Review," Journal of Clinical Epidemiology,
41, 923{937.
Yang, I. and Becker, M. P. (1997), \Latent Variable Modeling of Diagnostic Accuracy,"
Biometrics, 53, 948{958.
Zhou, X.-H., Castelluccio, P., and Zhou, C. (2005), \Nonparametric Estimation of ROC
Curves in the Absence of a Gold Standard," Biometrics, 61, 600{609.
270 0.2 0.4 0.6 0.8 1
0
0.2
0.4
0.6
0.8
1
K=10
1−Sp
S
e
0 0.2 0.4 0.6 0.8 1
0
0.2
0.4
0.6
0.8
1
K=20
1−Sp
S
e
0 0.2 0.4 0.6 0.8 1
0
0.2
0.4
0.6
0.8
1
K=50
1−Sp
S
e
0 0.2 0.4 0.6 0.8 1
0
0.2
0.4
0.6
0.8
1
K=100
1−Sp
S
e
Starting ROC
Bayesian Estimate
Seperate MLE
Figure 1: Nonparametric ROC estimation based on Bayesian models compared with the
separate MLE method for Johne's disease data. The dotted diagonal lines are the initial
starting lines of the MCMC chains. The continuous lines represent the ROC curves estimated
by the separate MLE method. The dashed lines represent the ROC curves computed by the
nonparametric method proposed here.
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Figure 2: Analysis of Johne's disease data: ¯rst 10,000 iterations for error rates ®1;1, ®1;10,
®1;19, ¯1;1, ¯1;10, ¯1;19 in the MCMC simulation. K = 20 in the model.
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Figure 3: Analysis of Johne's disease data. In upper panel, "¡4¡" and "¡r¡" give the
band within one standard deviation of the posterior mean, "¡o¡" and "¡¤¡" give the 95%
credible interval band. Lower panel compares (a) our Bayesian estimate with (b) separate
MLE estimate and (c) estimate as if Test2 is GS. K = 20 in the model.
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Figure 4: Analysis of Johne's disease data. Robustness of ROC curve estimates to choice
of subpopulation division: nonparametric ROC estimates based on Bayesian models (K=20,
lower panel), ROC estimates by separate MLE method (upper panel). Subpopulations are
created based on divisions by veterinary practitioner, herd size and postal zip code.
31Table 1: 2 £ (K + 1) table of probabilities and frequencies comparing Test 1 and Test 2 in
population g
Test 1
T1;1¡ T1;2¡; ... T1;i¡; ... T1;K¡;
T1;1+ ... T1;i¡1+ ... T1;K¡1+ T1;K+
T2+ p1;g p2;g ... pi;g ... pK;g pK+1;g
Test 2 x1;g;1 x2;g;1 ... xi;g;1 ... xK;g;1 xK+1;g;1
T2¡ q1;g q2;g ... qi;g ... qK;g qK+1;g
x1;g;2 x2;g;2 ... xi;g;2 ... xK;g;2 xK+1;g;2
See text for explanation of the notation.
32Table 2: Results of simulation study for a situation mimicking Johne's disease data set.
True mean(std) 2.5%(std) 97.5%(std) percentage of 95% CIs
value that include true value
AUC 0.78 0.764 (0.031) 0.669 (0.035) 0.855 (0.027) 100%
Sp2 0.98 0.977 (0.004) 0.966 (0.004) 0.988 (0.005) 95%
Se2 0.83 0.770 (0.104) 0.507 (0.109) 0.985 (0.038) 99%
Prev1 0.03 0.035 (0.012) 0.016 (0.006) 0.066 (0.023) 98%
Prev2 0.08 0.086 (0.016) 0.054 (0.009) 0.130 (0.026) 100%
AUC is AUC for Test 1. Sp2 and Se2 are the speci¯city and sensitivity for Test 2. Prev1
and Prev2 are the disease prevalences in populations 1 and 2, respectively.
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11. Introduction.
In order to evaluate the performance of the ROC estimation procedure described in the pa-
per [1] \Nonparametric Estimation of ROC Curves Based on Bayesian Models When the True
Disease State Is Unknown" by Wang, Turnbull, GrÄ ohn and Nielsen, a moderate size simulation
study was undertaken. Here we report the results. The paper [1] describes a procedure for es-
timating the ROC curve for a diagnostic test (Test 1) with responses measured on a continuous
scale. Available also is another diagnostic test (Test 2) which yields results on a binary scale (pos-
itive/negative), subject to error. Both tests are applied to individuals from G populations, with
samples of size ng from population g (1 · g · G). The notation used here is as de¯ned in that
paper.
2. Creation of a simulated data set.
In this study, each simulated data set contained two populations (G = 2), with 1250 individuals
in each (n1 = n2 = 1250:). The sample sizes here were chosen to be similar to those for our Johne's
disease application. For the each individual in the g'th population (g = 1;2), we ¯rst simulate
the true disease status (0 for healthy and 1 for diseased) according to a a binomial distribution
Bin(1;µg), where µg is the prevalence of the g'th population. Then, for each diseased individual in
either population, a Test 1 score is generated from a normal distribution N(¹1;¾2
1) and a Test 2 score
of 0 (negative) or 1 (positive) is generated with probabilities ¯2, and 1¡¯2, respectively. Similarly,
for each healthy individual, a Test 1 score is generated from a N(¹0;¾2
0) distribution and a Test 2
score of 0 or 1 is generated with probabilities 1 ¡ ®2, and ®2, respectively. Recall that ®2 and ¯2
are the (unknown) false positive rate (1-speci¯city) and false negative rate (1-sensitivity) for Test 2.
3. Factorial structure of the simulation experiment.
The performance of the estimation procedure was evaluated under 18 di®erent scenarios. These
included 12 scenarios where the true parameter con¯gurations implied non-identi¯ability. The pur-
pose of including these cases was to see the e®ect on the estimates produced and to see how well
these situations might be detected in practice. The e®ect of varying three factors was studied:
Factor A: Prevalences fµ1;µ2g.
Two choices of pairs were used:
A.1. fµ1 = 0:03;µ2 = 0:08g. These values are comparable with those found in our Johne's disease
application and are of the same order of magnitude reported by other authors.
A.2. fµ1 = µ2 = 0:055g. This is a non-identi¯able situation because the prevalences are equal. The
common value of 0.055 was chosen as the mean of the two prevalences in A1.
Factor B: ROC curves for Test 1.
As noted in Section 2 above, the ROC curve for Test 1 was based on a binormal model. Three
such models were considered:
2B.I. Distributions from the healthy and diseased individuals are normal with ¹0 = ¡0:33;¾2
0 = 0:12
and ¹1 = 0:33;¾2
1 = 0:63. These design values lead to an ROC curve similar to the Bayesian
estimate in our application (see Figure 3 of [1]). The AUC (area under the curve) is 0.78,
approximately the same as that found in the application.
B.II. The distributions are generated using ¹0 = ¹1 = 0;¾2
0 = 0:12;¾2
1 = 0:63. Here the variances
are the same as in B2, but the means are equal. The latter fact implies that the AUC = 0:5
and Test 1 has no diagnostic value at all.
B.III. The distributions are generated using ¹0 = ¡0:56;¹1 = 0:56;¾2
0 = 0:12;¾2
1 = 0:63. This is a
scenario where Test 1 is quite accurate with AUC = 0:9.
Factor C: Error rates for Test 2.
Three pairs ®2; ¯2 were considered for the false positive and false negative rates for Test 2:
C.i. ®2 = 0:02; ¯2 = 0:17. These were the values from our Johne's disease data set application,
estimated using the method proposed in [1].
C.ii. ®2 = 0; ¯2 = 0. This is the situation where Test 2 is a \gold standard" (GS) test, i.e. it
predicts perfectly.
C.iii. ®2 = 0:5; ¯2 = 0:5. In this case Test 2 has no diagnostic value at all, i.e. it is equivalent to
random guessing. This is a non-identi¯able situation because Test 2 provides no information
at all.
Thus, considering all combinations of factor levels, we have 2 £ 3 £ 3 = 18 scenarios. For each
scenario, one hundred data sets were simulated, producing a total of 1800 data sets, on each of
which the method in [1] was applied. In each case, the number of cuto® values used in the estima-
tion procedure was taken to be K = 20.
4. Choosing K cuto® values.
In the Johne's disease data set application in [1], we chose the set of f1=(K + 1);2=(K +
1);:::;K=(K + 1)g-quantiles of the observed Test 1 scores to be used as cuto® values in the model.
We call this Method CO 1. Such a choice insures balanced frequencies in the columns of Table 1 of
[1]. However, for cases when there is a large di®erence between the number of healthy and diseased
individuals and the test scores of the two groups (healthy and diseased) are well separated, Method
CO 1 will lead to insu±cient cuto® values in the range of test scores of the smaller group. When
the disease prevalences are very low and the AUC is close to one, lack of cuto® values in this region,
where the sensitivity is increasing rapidly to 1 on the ROC curve, will lead to underestimates of
the AUC. And this was borne out by the simulations results presented in the next section.
We can use an alternative method to construct cuto® values | Method CO 2, say, | in
order to help to resolve the problem. Denote the number of Test 2 positive and Test 2 nega-
tive individuals are m =
P
g mg and n =
P
g ng, respectively. For each individual, we generate
duplicate observations all with the same Test 1 score as this individual | n duplicates if it is
Test 2 positive, and m duplicates if it is Test 2 negative. By doing this, we will have a sample of
32 ¢ m ¢ n scores, now with equal numbers of scores in the two groups. Then we chose the set of
f1=(K+1);2=(K+1);:::;K=(K+1)g-quantiles of these Test 1 scores in the new augmented sample
to be used as the cuto® values in the model. Compared to Method CO 1, an increased proportion
of the cuto® values may be taken over the range of the smaller group. If the disease prevalences
are very low, Method CO 2 will lead to more cuto® points in the region where the sensitivity is in-
creasing to 1, which happens rapidly on the ROC curve in this situation when the AUC is close to 1.
5. Results.
Table 1 and 2 list the simulation results for the 18 situations, with 100 simulated samples for
each situation, for the two methods to chose cuto® values respectively. In particular, the listed
results include, as well as the true value, the means and standard deviations of the estimates and
95% credible intervals, for the quantities of interest, namely the AUC of Test 1, sensitivity (1¡¯2)
and speci¯city (1¡®2) of Test 2 and the prevalences fµ1;µ2g of the two populations. Also provided
are the number of samples (out of 100) that \°ag" a potential non-identi¯able situation (fµ1 = µ2g
or ®2 + ¯2 = 1) according to the two criteria proposed in Section 5 of [1].
6. Discussion.
In Table 1, it can be seen that in Scenario 1 (1,I,i), which mimics the situation for the Johne's
disease data set application, the estimation procedure provides quite satisfactory results with point
and interval estimates close to the true values. The same is true for the other ¯ve identi¯able
scenarios | f(1,II,i),(1,III,i),(1,I,ii),(1,II,ii),(1,III,ii)g. At most 2 of the 100 simulated data sets
°agged a non-identi¯able situation in each of these cases. However a high percentage of the re-
maining 12 non-identi¯able situations led to warnings that a non-identi¯able situation could exist.
Of course, except in such arti¯cially created data sets, it is almost impossible to have µ1 = µ2. It is
also unlikely in a real application, that any proposed diagnostic procedure, with su±cient promise
that it is being tested in substantial experiment, will be not at all better than random guessing
(®2 + ¯2 = 1). It is interesting to note that in those non-identi¯able cases 10{15, where Test 2 is
better than random guessing, estimates of the value of Test 1, as measured by AUC, remain quite
accurate, despite equality of the true prevalences (µ1 = µ2 = 0:055).
For true Test 1 AUC values close to 1, the estimation procedure using Method CO 1 to choose
cuto® values underestimated the AUC (Scenario 3 in Table 1). This is improved by using Method
CO 2, as shown in Table 2. For other situations, Table 2 suggests Method CO 2 performs similarly
to Method CO 1. Since the latter method is simpler, we stay with this as a preferred method in
the submitted revised manuscript.
Of course, it is realized that like any simulation study, this one is necessarily limited in scope.
It is impossible to cover all possible choices of design parameters. However this study does suggest
that the proposed estimation procedure in [1] is quite feasible and practical to carry out in a
variety of situations and that it does produce answers that are reasonable and reliable in the cases
considered. In any particular application, a similar simulation study could be undertaken with the
appropriate approximate design parameters (sample sizes, prevalences, error rates, etc.) if it is
important to assess the performance of the estimation procedure in that precise situation.
4Table 1: Results of simulation study for 18 Scenarios. Cuto® values are chosen using Method CO 1
as in the submitted manuscript.
S1 (1,I,i) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.780 0.764 (0.031) 0.669 (0.035) 0.855 (0.027)
Sp2 0.980 0.977 (0.004) 0.966 (0.004) 0.988 (0.005) 0%
Se2 0.830 0.770 (0.104) 0.507 (0.109) 0.985 (0.038) 0%
Prev1 0.030 0.035 (0.012) 0.016 (0.006) 0.066 (0.023) 0%
Prev2 0.080 0.086 (0.016) 0.054 (0.009) 0.130 (0.026)
S2 (1,II,i) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.500 0.498 (0.043) 0.388 (0.044) 0.607 (0.043)
Sp2 0.980 0.970 (0.005) 0.957 (0.005) 0.982 (0.006) 0%
Se2 0.830 0.669 (0.157) 0.360 (0.132) 0.957 (0.118) 2%
Prev1 0.030 0.040 (0.043) 0.011 (0.016) 0.095 (0.077) 2%
Prev2 0.080 0.099 (0.044) 0.050 (0.019) 0.175 (0.075)
S3 (1,III,i) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.900 0.840 (0.022) 0.762 (0.027) 0.909 (0.017)
Sp2 0.980 0.983 (0.003) 0.974 (0.004) 0.992 (0.003) 0%
Se2 0.830 0.777 (0.094) 0.592 (0.082) 0.956 (0.072) 0%
Prev1 0.030 0.039 (0.009) 0.022 (0.006) 0.061 (0.012) 0%
Prev2 0.080 0.092 (0.011) 0.065 (0.010) 0.123 (0.013)
S4 (1,I,ii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.780 0.792 (0.026) 0.715 (0.030) 0.864 (0.022)
Sp2 1.000 0.992 (0.003) 0.985 (0.004) 0.999 (0.002) 0%
Se2 1.000 0.864 (0.083) 0.653 (0.113) 0.989 (0.036) 0%
Prev1 0.030 0.030 (0.007) 0.017 (0.005) 0.049 (0.012) 0%
Prev2 0.080 0.085 (0.013) 0.062 (0.009) 0.115 (0.018)
S5 (1,II,ii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.500 0.504 (0.036) 0.411 (0.036) 0.598 (0.038)
Sp2 1.000 0.987 (0.004) 0.976 (0.005) 0.996 (0.004) 0%
Se2 1.000 0.754 (0.147) 0.474 (0.139) 0.967 (0.105) 1%
Prev1 0.030 0.032 (0.022) 0.013 (0.011) 0.062 (0.037) 1%
Prev2 0.080 0.096 (0.028) 0.059 (0.016) 0.152 (0.044)
S6 (1,III,ii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.900 0.885 (0.014) 0.829 (0.018) 0.932 (0.011)
Sp2 1.000 0.998 (0.001) 0.993 (0.002) 1.000 (0.000) 0%
Se2 1.000 0.921 (0.052) 0.778 (0.075) 0.995 (0.022) 0%
Prev1 0.030 0.031 (0.006) 0.021 (0.005) 0.045 (0.007) 0%
Prev2 0.080 0.084 (0.008) 0.066 (0.007) 0.104 (0.009)
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S7 (1,I,iii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.780 0.515 (0.067) 0.381 (0.074) 0.649 (0.080)
Sp2 0.500 0.517 (0.012) 0.490 (0.010) 0.548 (0.019) 81%
Se2 0.500 0.597 (0.094) 0.502 (0.019) 0.730 (0.180) 94%
Prev1 0.030 0.250 (0.157) 0.125 (0.119) 0.394 (0.190) 60%
Prev2 0.080 0.262 (0.164) 0.137 (0.120) 0.403 (0.199)
S8 (1,II,iii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.500 0.497 (0.052) 0.354 (0.063) 0.637 (0.071)
Sp2 0.500 0.517 (0.013) 0.490 (0.011) 0.549 (0.020) 76%
Se2 0.500 0.616 (0.106) 0.504 (0.025) 0.767 (0.190) 97%
Prev1 0.030 0.238 (0.168) 0.117 (0.134) 0.374 (0.201) 79%
Prev2 0.080 0.244 (0.164) 0.121 (0.128) 0.383 (0.198)
S9 (1,III,iii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.900 0.545 (0.086) 0.424 (0.090) 0.667 (0.098)
Sp2 0.500 0.516 (0.014) 0.490 (0.012) 0.547 (0.019) 87%
Se2 0.500 0.568 (0.066) 0.497 (0.014) 0.682 (0.152) 92%
Prev1 0.030 0.259 (0.178) 0.135 (0.146) 0.402 (0.210) 34%
Prev2 0.080 0.301 (0.152) 0.170 (0.133) 0.447 (0.174)
S10 (2,I,i) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.780 0.772 (0.030) 0.674 (0.034) 0.864 (0.026)
Sp2 0.980 0.976 (0.005) 0.965 (0.005) 0.987 (0.005) 0%
Se2 0.830 0.615 (0.128) 0.395 (0.070) 0.883 (0.144) 96%
Prev1 0.055 0.078 (0.016) 0.043 (0.012) 0.122 (0.020) 96%
Prev2 0.055 0.074 (0.018) 0.040 (0.013) 0.118 (0.023)
S11 (2,II,i) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.500 0.499 (0.044) 0.392 (0.047) 0.607 (0.045)
Sp2 0.980 0.971 (0.005) 0.958 (0.006) 0.984 (0.006) 0%
Se2 0.830 0.294 (0.126) 0.171 (0.048) 0.540 (0.268) 96%
Prev1 0.055 0.175 (0.066) 0.086 (0.052) 0.276 (0.087) 96%
Prev2 0.055 0.175 (0.064) 0.087 (0.054) 0.276 (0.085)
S12 (2,III,i) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.900 0.839 (0.021) 0.759 (0.025) 0.910 (0.016)
Sp2 0.980 0.984 (0.004) 0.974 (0.004) 0.993 (0.004) 0%
Se2 0.830 0.765 (0.080) 0.574 (0.068) 0.973 (0.051) 98%
Prev1 0.055 0.067 (0.009) 0.043 (0.007) 0.094 (0.012) 98%
Prev2 0.055 0.066 (0.009) 0.042 (0.006) 0.093 (0.011)
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S13 (2,I,ii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.780 0.802 (0.029) 0.720 (0.032) 0.878 (0.025)
Sp2 1.000 0.990 (0.003) 0.982 (0.004) 0.998 (0.002) 0%
Se2 1.000 0.698 (0.083) 0.476 (0.071) 0.977 (0.053) 93%
Prev1 0.055 0.070 (0.011) 0.040 (0.008) 0.105 (0.014) 93%
Prev2 0.055 0.071 (0.012) 0.041 (0.008) 0.107 (0.015)
S14 (2,II,ii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.500 0.508 (0.041) 0.406 (0.041) 0.608 (0.044)
Sp2 1.000 0.982 (0.004) 0.971 (0.004) 0.992 (0.004) 0%
Se2 1.000 0.367 (0.158) 0.213 (0.063) 0.594 (0.261) 94%
Prev1 0.055 0.131 (0.038) 0.072 (0.035) 0.202 (0.045) 94%
Prev2 0.055 0.131 (0.038) 0.072 (0.033) 0.203 (0.046)
S15 (2,III,ii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.900 0.887 (0.014) 0.830 (0.018) 0.936 (0.010)
Sp2 1.000 0.997 (0.001) 0.992 (0.002) 1.000 (0.000) 0%
Se2 1.000 0.856 (0.051) 0.703 (0.062) 0.994 (0.014) 95%
Prev1 0.055 0.063 (0.007) 0.045 (0.006) 0.083 (0.008) 95%
Prev2 0.055 0.063 (0.007) 0.046 (0.006) 0.083 (0.008)
S16 (2,I,iii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.730 0.503 (0.054) 0.364 (0.075) 0.642 (0.057)
Sp2 0.500 0.520 (0.015) 0.493 (0.010) 0.553 (0.023) 66%
Se2 0.500 0.619 (0.109) 0.508 (0.030) 0.771 (0.187) 93%
Prev1 0.055 0.255 (0.177) 0.131 (0.148) 0.394 (0.209) 82%
Prev2 0.055 0.251 (0.176) 0.124 (0.140) 0.394 (0.210)
S17 (2,II,iii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.500 0.499 (0.049) 0.356 (0.066) 0.641 (0.064)
Sp2 0.500 0.516 (0.014) 0.489 (0.011) 0.546 (0.019) 76%
Se2 0.500 0.618 (0.101) 0.504 (0.018) 0.780 (0.190) 95%
Prev1 0.055 0.245 (0.171) 0.116 (0.131) 0.390 (0.198) 88%
Prev2 0.055 0.247 (0.178) 0.121 (0.143) 0.390 (0.201)
S18 (2,III,iii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.900 0.508 (0.046) 0.373 (0.061) 0.643 (0.064)
Sp2 0.500 0.519 (0.016) 0.491 (0.013) 0.553 (0.024) 78%
Se2 0.500 0.608 (0.099) 0.502 (0.017) 0.757 (0.188) 97%
Prev1 0.055 0.264 (0.172) 0.134 (0.138) 0.407 (0.201) 90%
Prev2 0.055 0.267 (0.181) 0.142 (0.146) 0.413 (0.214)
7Table 2: Results of simulation study for 18 Scenarios. Cuto® values are chosen by using alternate
Method CO 2.
S1 (1,I,i) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.780 0.788 (0.031) 0.690 (0.034) 0.879 (0.025)
Sp2 0.980 0.974 (0.004) 0.964 (0.004) 0.985 (0.005) 0%
Se2 0.830 0.878 (0.047) 0.714 (0.068) 0.994 (0.012) 0%
Prev1 0.030 0.024 (0.006) 0.013 (0.004) 0.039 (0.008) 0%
Prev2 0.080 0.070 (0.010) 0.049 (0.008) 0.095 (0.013)
S2 (1,II,i) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.500 0.500 (0.046) 0.384 (0.047) 0.616 (0.046)
Sp2 0.980 0.968 (0.005) 0.956 (0.005) 0.979 (0.006) 0%
Se2 0.830 0.789 (0.099) 0.516 (0.115) 0.989 (0.031) 2%
Prev1 0.030 0.022 (0.008) 0.008 (0.004) 0.046 (0.015) 2%
Prev2 0.080 0.070 (0.013) 0.042 (0.009) 0.111 (0.023)
S3 (1,III,i) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.900 0.868 (0.022) 0.789 (0.027) 0.934 (0.015)
Sp2 0.980 0.980 (0.003) 0.971 (0.004) 0.989 (0.003) 0%
Se2 0.830 0.887 (0.052) 0.762 (0.066) 0.988 (0.023) 0%
Prev1 0.030 0.029 (0.005) 0.018 (0.004) 0.043 (0.006) 0%
Prev2 0.080 0.076 (0.009) 0.057 (0.007) 0.098 (0.010)
S4 (1,I,ii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.780 0.815 (0.028) 0.734 (0.032) 0.890 (0.023)
Sp2 1.000 0.991 (0.003) 0.982 (0.004) 0.998 (0.002) 0%
Se2 1.000 0.978 (0.011) 0.904 (0.035) 1.000 (0.000) 0%
Prev1 0.030 0.023 (0.005) 0.014 (0.004) 0.034 (0.006) 0%
Prev2 0.080 0.072 (0.008) 0.055 (0.007) 0.090 (0.009)
S5 (1,II,ii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.500 0.507 (0.038) 0.406 (0.038) 0.608 (0.039)
Sp2 1.000 0.984 (0.004) 0.974 (0.004) 0.994 (0.004) 0%
Se2 1.000 0.909 (0.051) 0.719 (0.097) 0.999 (0.005) 0%
Prev1 0.030 0.020 (0.005) 0.010 (0.003) 0.034 (0.007) 0%
Prev2 0.080 0.070 (0.010) 0.049 (0.008) 0.098 (0.015)
S6 (1,III,ii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.900 0.907 (0.014) 0.852 (0.018) 0.953 (0.011)
Sp2 1.000 0.996 (0.002) 0.991 (0.002) 1.000 (0.001) 0%
Se2 1.000 0.990 (0.003) 0.950 (0.011) 1.000 (0.000) 0%
Prev1 0.030 0.028 (0.005) 0.019 (0.004) 0.038 (0.006) 0%
Prev2 0.080 0.077 (0.007) 0.062 (0.006) 0.093 (0.008)
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S7 (1,I,iii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.780 0.509 (0.066) 0.375 (0.070) 0.643 (0.086)
Sp2 0.500 0.517 (0.013) 0.490 (0.010) 0.548 (0.019) 79%
Se2 0.500 0.604 (0.104) 0.501 (0.018) 0.741 (0.186) 92%
Prev1 0.030 0.260 (0.185) 0.133 (0.149) 0.398 (0.215) 56%
Prev2 0.080 0.275 (0.176) 0.145 (0.146) 0.416 (0.202)
S8 (1,II,iii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.500 0.498 (0.054) 0.361 (0.068) 0.637 (0.064)
Sp2 0.500 0.518 (0.014) 0.490 (0.011) 0.550 (0.019) 75%
Se2 0.500 0.605 (0.098) 0.501 (0.014) 0.749 (0.184) 98%
Prev1 0.030 0.257 (0.159) 0.124 (0.122) 0.409 (0.187) 81%
Prev2 0.080 0.269 (0.169) 0.129 (0.130) 0.420 (0.198)
S9 (1,III,iii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.900 0.547 (0.078) 0.418 (0.088) 0.678 (0.083)
Sp2 0.500 0.516 (0.013) 0.490 (0.011) 0.546 (0.019) 81%
Se2 0.500 0.585 (0.080) 0.501 (0.021) 0.715 (0.165) 92%
Prev1 0.030 0.222 (0.157) 0.107 (0.130) 0.360 (0.174) 44%
Prev2 0.080 0.271 (0.153) 0.151 (0.130) 0.408 (0.166)
S10 (2,I,i) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.780 0.795 (0.029) 0.693 (0.033) 0.888 (0.026)
Sp2 0.980 0.973 (0.004) 0.962 (0.004) 0.984 (0.004) 0%
Se2 0.830 0.867 (0.059) 0.682 (0.085) 0.995 (0.012) 96%
Prev1 0.055 0.047 (0.007) 0.030 (0.006) 0.068 (0.009) 96%
Prev2 0.055 0.044 (0.008) 0.028 (0.006) 0.065 (0.011)
S11 (2,II,i) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.500 0.506 (0.050) 0.385 (0.050) 0.627 (0.050)
Sp2 0.980 0.966 (0.005) 0.954 (0.006) 0.978 (0.005) 0%
Se2 0.830 0.673 (0.163) 0.427 (0.151) 0.945 (0.128) 96%
Prev1 0.055 0.058 (0.030) 0.028 (0.010) 0.102 (0.057) 96%
Prev2 0.055 0.057 (0.025) 0.027 (0.009) 0.101 (0.052)
S12 (2,III,i) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.900 0.863 (0.019) 0.780 (0.026) 0.934 (0.012)
Sp2 0.980 0.981 (0.004) 0.971 (0.004) 0.990 (0.004) 0%
Se2 0.830 0.913 (0.036) 0.781 (0.057) 0.998 (0.007) 97%
Prev1 0.055 0.051 (0.007) 0.036 (0.006) 0.070 (0.009) 97%
Prev2 0.055 0.051 (0.007) 0.036 (0.006) 0.069 (0.008)
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S13 (2,I,ii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.780 0.826 (0.028) 0.740 (0.032) 0.903 (0.024)
Sp2 1.000 0.987 (0.003) 0.979 (0.004) 0.996 (0.003) 0%
Se2 1.000 0.977 (0.009) 0.897 (0.032) 1.000 (0.000) 96%
Prev1 0.055 0.044 (0.007) 0.032 (0.006) 0.059 (0.008) 96%
Prev2 0.055 0.045 (0.006) 0.032 (0.005) 0.060 (0.007)
S14 (2,II,ii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.500 0.511 (0.047) 0.398 (0.045) 0.624 (0.049)
Sp2 1.000 0.978 (0.004) 0.968 (0.004) 0.988 (0.004) 0%
Se2 1.000 0.875 (0.079) 0.666 (0.125) 0.997 (0.009) 98%
Prev1 0.055 0.040 (0.008) 0.024 (0.006) 0.061 (0.012) 98%
Prev2 0.055 0.041 (0.008) 0.025 (0.006) 0.062 (0.013)
S15 (2,III,ii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.900 0.911 (0.014) 0.854 (0.018) 0.958 (0.009)
Sp2 1.000 0.995 (0.002) 0.990 (0.003) 1.000 (0.001) 0%
Se2 1.000 0.990 (0.003) 0.951 (0.013) 1.000 (0.000) 94%
Prev1 0.055 0.051 (0.006) 0.039 (0.006) 0.065 (0.007) 94%
Prev2 0.055 0.053 (0.007) 0.040 (0.006) 0.067 (0.007)
S16 (2,I,iii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.730 0.504 (0.049) 0.366 (0.070) 0.648 (0.065)
Sp2 0.500 0.521 (0.016) 0.493 (0.012) 0.554 (0.023) 63%
Se2 0.500 0.627 (0.112) 0.509 (0.033) 0.778 (0.188) 95%
Prev1 0.055 0.245 (0.182) 0.133 (0.143) 0.378 (0.218) 86%
Prev2 0.055 0.245 (0.182) 0.132 (0.145) 0.378 (0.216)
S17 (2,II,iii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.500 0.498 (0.043) 0.351 (0.060) 0.646 (0.057)
Sp2 0.500 0.515 (0.013) 0.489 (0.011) 0.545 (0.017) 79%
Se2 0.500 0.625 (0.108) 0.506 (0.023) 0.783 (0.183) 96%
Prev1 0.055 0.223 (0.156) 0.103 (0.120) 0.357 (0.196) 81%
Prev2 0.055 0.221 (0.157) 0.103 (0.123) 0.363 (0.198)
S18 (2,III,iii) TRUE mean(std) 2.5%(std) 97.5%(std) Flag1 Flag2 at least one °ag
AUC 0.900 0.503 (0.054) 0.368 (0.066) 0.636 (0.069)
Sp2 0.500 0.519 (0.014) 0.491 (0.011) 0.551 (0.020) 80%
Se2 0.500 0.602 (0.102) 0.501 (0.020) 0.738 (0.190) 99%
Prev1 0.055 0.283 (0.173) 0.154 (0.143) 0.424 (0.198) 84%
Prev2 0.055 0.269 (0.169) 0.141 (0.135) 0.409 (0.201)
10Reference.
1 Wang, C., Turnbull, B.W., GrÄ ohn, Y.T. and Nielsen, S.S. (2006). Nonparametric estimation
of ROC curves based on Bayesian models when the true disease state is unknown.
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